Our Solutions   Gefitero 250 mg Tablets

Gefitero 250 mg Tablets

Gefitero 250 mg Tablets

*To be consumed as directed by physician.

Therapies:

Anti Neoplastics

Composition:

Gefitinib (250 mg)

About Gefitero 250 mg Tablets

Gefitero 250 mg Tablets is an anti-cancer medicine primarily used in the treatment of certain types of non-small cell lung cancer (NSCLC). It contains Gefitinib 250 mg as its active composition, which belongs to the class of targeted therapy medicines known as epidermal growth factor receptor (EGFR) inhibitors. Gefitinib works by blocking the EGFR protein responsible for the growth and spread of cancer cells and helps slow down or stop tumour progression. This targeted mechanism makes the medicine effective in patients with specific EGFR gene mutations, while also supporting better disease management and improved treatment outcomes under medical supervision.

Gefitero 250 mg Tablets

*To be consumed as directed by physician.


Usage Instructions

  • Gefitero Tablet should be used strictly according to the dosage prescribed by your doctor.
  • Continue taking the medicine for the duration recommended by your healthcare provider, as the treatment period may differ based on your medical condition and how well your body responds to therapy.
  • Your doctor may also suggest routine liver function tests during treatment to ensure safe and effective use of the medicine.

Benefits and Use

  • Gefitero 250 mg Tablets is primarily used in the treatment of certain types of non-small cell lung cancer (NSCLC) that carry specific EGFR mutations.
  • It works by blocking the activity of abnormal proteins that promote the growth and spread of cancer cells, thereby helping to slow disease progression.
  • The medicine may help improve breathing difficulties, persistent cough, and chest discomfort associated with lung cancer.
  • When taken as prescribed, it can support better disease management and improve overall quality of life in eligible patients.

Safety Information

  • Alcohol
    • Avoid consuming alcohol during treatment, as it may increase the risk of side effects and put extra strain on the liver.
  • Pregnancy
    • Gefitinib 250 mg Tablet is not recommended during pregnancy because it may harm the developing baby.
  • Breastfeeding
    • Breastfeeding should be avoided while taking this medicine, as it may pass into breast milk and affect the infant.
  • Liver
    • Patients with liver disorders should use this medicine cautiously and may require regular liver function monitoring.
  • Kidney
    • Gefitinib 250 mg Tablet should be used cautiously in patients with kidney problems, and medical supervision is suggested during treatment.

Ingredients

Gefitinib 250 mg

How to Use

  • Gefitero 250 mg Tablets should be taken as directed by the physician, ideally at the same time every day to maintain constant levels of the medicine in the body.
  • Swallow the tablet with water without crushing or chewing it.
  • It can be taken with or without food.
  • Patients are encouraged not to skip doses or discontinue the prescription without medical assistance, as regular treatment plays a crucial role in managing cancer effectively.

Storage Information

Store below 30°C